Haematology Transfusion Flashcards

1
Q

Blood Donors

A
  1. Healthy volunteer donor
  2. Age 17-70 (no age limit for regular donors)
    a. Medically assessed
    i. History
    ii. Medication
    iii. Travel
    b. Fingerprick Hb
    i. Women >12.5
    ii. Men >13.5 g/dl
  3. 450 ml collected, up to every 12 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Apheresis donation and therapy

A
  • Selective removal of the component required platelets or plasma (occasionally red cells)
  • Up to 3 adult doses of platelets/donor visit
  • Also used for therapeutic removal of plasma/WBC/platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Processing

A
  • Leucocyte depletion – reduces WCC reaction to recipiant
  • Split into red cells/platelets/Plasma
  • Special processes (to order): irradiation, washing, hyper-concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood components available

A

Plasma
Platelets (Granulocytes) – rare cases
Red cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Plasma

A

Fractionated plasma proteins – albumin/clotting factors
Fresh frozen plasma (for clotting factors)
Cryoprocipitate – rich in fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Red cells: Used for

A

Blood loss

Anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Red cells: Storage

A

In additive solution
• 280+/-60 ml (slightly more concentrated)
• 0.5-0.7 haematocrit
Risk of bacterial infection post refrigeration (only 4hrs transfusion time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Red cells: Shelf life

A

35 day shelf life at 4 degrees

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Platelet Concentration: Used for

A

Thrombocytopenia

Platelet dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Platelet Concentration: Collection process

A

Pooled from 4-6 donors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Platelet Concentration: Apheresis

A

Single donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Platelet Concentration: Storage

A

22 +/- 2oC (room temp) for 5 days on an agitator (7 days if bacterial screening)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fresh Frozen Plasma: Used for

A

Replacement of clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fresh Frozen Plasma: Storage

A

Plasma fraction frozen to -30oC
Stored up to 3 yrs
20 mins to defrost
Infuse with 4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fresh Frozen Plasma: Virally inactivation via and used for

A

Children and if using large volumes:
• Methylene Blue Treatment
• Solvent detergent treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cryoprecipitate: Formed

A

Precipitate formed when defrosting FFP – rich in fibrinogen (Factor 8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cryoprecipitate: Contain

A

Rich in fibrinogen
Factor 8
VWF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cryoprecipitate: Used

A

For fibrinogen supplementation – mostly bleeding patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cryoprecipitate: Virally

A

Inactivation (methylene blue) available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Fractionated blood products: Prepared from

A

They are pharmaceutical products

Prepared from pooled plasma from many donors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Fractionated blood products: Contain

A

Albumin
Clotting factor concentrates
Intravenous immunoglobulin
Disease – specific immunoglobulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hazards of Transfusions

A
  1. Unavailable blood
  2. Transfusion transmitted infections
  3. Immunological reactions
  4. Overloading:
    a. Iron
    b. Fluid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Lack of Blood

A

WHO:

  1. Each year, more than 500000 women die needlessly during pregnancy or childbirth
  2. Severe bleeding can kill even a healthy woman with 2 hrs if she is unattended = 44% of maternal deaths in Africa
  3. Up to one-fourth of all maternal deaths could be saved by access to safe blood transfusion
  4. Also happens in developed worl – usually organisational problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Transfusion transmitted infection: virus

A
HIV
HBV
HCV
CMV
HTLV1
Parovirus
West Nile Virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Transfusion transmitted infections: Protozoa

A

Malaria
Trypanosomes
Syphilus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Transfusion transmitted infections: Bacteria

A

Staphylococci (Skin)

Yersinia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Transfusion transmitted infections: Prions

A

CJD (4 documented cases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Prevention of Infections:

A
  1. Donor Selection – volunteer vs. paid
  2. Testing of blood
  3. Pathogen inactivation –
  4. Avoiding transfusion

See pg27 for effectiveness of testing for infections

29
Q

Immunological reactions: Red cells

A

Blood Groups: (polymorphic proteins)
• Immediate haemolysis
• Delayed Haemolysis
• Haemolytic disease of the newborn

30
Q

Immunological reactions: Platelets

A

Post transfusion purpura

HPA – human platelet antigens

31
Q

Immunological reactions: Lymphocytes/HLA (neutrophil antigens)

A

Graft versus host disease

32
Q

Immunological reactions: Plasma Proteins

A

Allergy/Anaphylaxis

Donor exposure – drugs/food

33
Q

Blood Groups: Inheritance

A

Inherited variation of red cell membrane proteins
• ABO system
• Rh system (DCE)
• MNS, K, Fy, Jk, Le, Lu

34
Q

Blood Groups: Antibody reactions

A

Can be formed against transfused antigens

35
Q

Blood Groups: Antibodies can cause haemolysis

A
  • Of the transfused blood
  • Of the recipient blood
  • In the fetus/newborn (Haemolytic Disease of the Newborn
36
Q

Blood Groups:The incompatible transfusion: Major Compatibility

A
  • Recipient has antibodies against transfused blood

* E.g. group A blood given to group O patient

37
Q

Blood Groups: The incompatible transfusion: Minor Compatibility

A
  • Transfused blood contains antibodies against recipient cells
  • E.g. group O blood transfused to group A patient
38
Q

Most common blood groups

A

O then A

39
Q

Rare blood groups

A

AB

40
Q

The basis of the ABO blood group system: explanation

A
  • Virtually all humans express the H antigen on the surfaces of their red cells. This is therefore not antigenic = Group O
  • A transferase (alpha – 3-N-acetyl-D galactosaminyltransferase) converts H to A (A and H expressed)
  • B transferase (alpha – 3-N-acetyl-D galactosyltransferase) converts the H antigen into the B antigen (B and h expressed).
41
Q

Importance of the ABO system:

A
  • Humans form antibodies against the ABO antigens they lack
  • Naturally occurring antibodies
  • Stimulated by micro-organisms expressing glycoproteins similar to the ABO antigens
  • Usually present by 4 months of age
  • Antibodies can cause immediate haemolysis
42
Q

Universal donor

A

O

43
Q

Universal donor for plasma

A

AB

44
Q

Positive negativity refers to

A

RhD

45
Q

White cells: Graft versus host disease (TA-GVHD)

A
  • Donor T cells react against the recipient
  • Immunodeficient recipient or of close HLA type to the donor
  • Fever, skin rash, hepatitis, diarrhoea, pancytopenia
  • Usually fatal but preventable
46
Q

White cells: Graft versus host disease (TA-GVHD)

Prevention

A

Gamma irradiation of cellular blood components for susceptible recipients

47
Q

Immunological reactions: platelets post transfusion purpura

A

Systems of human platelet antigens (HPa)
Anti HPA antibodies detectable in the patient’s serum.
Purpura, bleeding and thrombocytopenia
5-12 days after transfusion

48
Q

Immunological reactions: platelets post transfusion purpura treatment

A

High-dose ivlg 0.4g/kg for 5 days

49
Q

Reactions against plasma proteins (common)

A

Allergic reactions
• Analphylaxis
• Rash
Febrile reactions

50
Q

Iron overload 1 unit red cells contains

A

Iron overload 1 unit red cells contains

51
Q

250mg iron

A

3mg/day

52
Q

Cause of iron overload

A

Regular transfusion (several years)

53
Q

Toxicity of iron overload

A
Heart
Liver
Pancreas
Joints
Pituitary
54
Q

Treatment of iron overload

A

Minimise transfusion

Long term iron chelation (desferrioxamine [s/c] or deferasirox/deferiprone [oral])

55
Q

Transfusion associated circulatory overload: Epi

A
  • Greatest cause of transfusion in UK
  • Occurs late in infusion, uncommon in clinical areas experienced in blood transfusion
  • Early signs can be detected (raised pulse and BP at 15 mins)
56
Q

Transfusion associated circulatory overload: Treatment

A

• Slow down the infusion and give frusemide

57
Q

Transfusion associated circulatory overload: Prevention

A
  • Identify at risk patients.
  • Give frusemide with transfusion
  • 1 unit at a time.
58
Q

The transfusion process

A
  • ABO Grouping
  • Antibody screen
  • Cross-match (mix donor cells + recipient serum)
  • Cross check with previous records (send second sample if no previous sample)
59
Q

Causes of ABO incompatibility:

A

• Almost always due to patient receiving blood meant for another recipient
• Almost always preventable
• Most common errors:
o Failure to check patient identity at the bedside against the unit to be transfused
o Labelling sample tube away from the patient
o Sample transposition in laboratory

60
Q

When to transfuse red cells

A
  • Acute blood loss >30% of blood volume
  • Symptomatic anaemi (usually <7g/dl)
  • It is better to treat the cause of the anaemia than to transfuse in most circumstances
  • Investigate cause of anaemia before transfusion
  • It may be dangerous to transfuse patients with B12 or folate deficiency, a paraprotein or sickle cell disease without consulting a haematologist
61
Q

When to prescribe platelets

A
  • Ensure the reason for low platelets is known

* Bone marrow failure in a well patient if plt <100x109/l

62
Q

When NOT to prescribe platelets

A
  • Consumption of platelets (e.g. ITP, drug induced) unless major bleeding.
  • TTP (Thrombocytopenic thrombotic purpura)
  • Irreversible marrow failure (e.g. aplastic anaemia) – only transfuse if bleeding.
63
Q

Indications for FFP

A

For clotting factor replacement:
• Coagulation factor deficiencies when specific factor concentrates are not available
• Multiple coagulation factor deficiencies
→Liver disease
→ Diseminated intravascular coagulation
→ Massive transfusion

• Warfarin reversal with severe bleeding (PC concentrate is preferred choice)

64
Q

Indications for cryoprecipitate

A
  • Fibrinogen supplementation
  • If there is bleeding and a fibrinogen level <1.5 g/l
  • E.g. DIC advanced liver disease, massive blood transfusion, obstetric bleeding and reversal of fibrinolytic therapy
65
Q

Alternatives to Transfusion:

A
  1. Avoid anaemia/blood loss
    a. Reducing blood sampling
    b. Preoperative optimisation
    c. Tranexamic acid
  2. Treat anaemia
    a. Identify cause and treat
    b. IV iron, erythropoietin
  3. Intraoperative cell salvage
  4. Artificial blood substitutes?
66
Q

Special Requirements:

A

Irradiated blood:
• To prevent
• Used for
CNV negative blood

67
Q

Irradiated blood:
• To prevent
• Used for

A

Prevents GvHD
• Haematology patients (specific conditions and treatments)
• Congenital T cell immunodeficiency
• Intrauterine transfusion/neonatal exchange transfusion
• (Transfusion of blood from a relative)

68
Q

CNV negative blood

A

Unit does not have anti-CMV antibodies
Neonates under 28 days post term
Elective transfusion in pregnancy (not needed for obstetric haemorrhage)

69
Q

Acute complications:

A
  1. Acute transfusion reaction →
    a. Acute haemolysis
    b. Bacterial contamination
  2. Acute breathlessness
    a. Fluid overload
    b. Anaphylaxis
    c. Transfusion related head injury
  3. Minor reactions
    a. Rash
    b. Febrile reaction